000999 华润三九
已收盘 09-30 15:00:00
资讯
新帖
简况
华润三九半年营销费用41亿,挣来16.7亿净利润
市场资讯 · 09-20
华润三九半年营销费用41亿,挣来16.7亿净利润
华特达因:华润三九是公司维生素D滴剂(胶囊型)产品在中国境内的独家代理商
证券之星 · 09-16
华特达因:华润三九是公司维生素D滴剂(胶囊型)产品在中国境内的独家代理商
“求‘你们’中秋别团圆了”,400亿中药龙头广告翻车
市场资讯 · 09-15
“求‘你们’中秋别团圆了”,400亿中药龙头广告翻车
华润三九:公司无相关计划
证券之星 · 09-14
华润三九:公司无相关计划
华润三九:公司及子公司高度重视中选产品的落地执行与市场转化
证券之星 · 09-14
华润三九:公司及子公司高度重视中选产品的落地执行与市场转化
华润三九:中药1.1类创新药枣仁宁心滴丸于2026年6月获批上市
证券之星 · 09-14
华润三九:中药1.1类创新药枣仁宁心滴丸于2026年6月获批上市
华润三九:坚持“创新+品牌”双轮驱动
证券之星 · 09-14
华润三九:坚持“创新+品牌”双轮驱动
华润三九:坚持以临床价值为导向
证券之星 · 09-14
华润三九:坚持以临床价值为导向
股市必读:华润三九新发布《2026年第二次临时股东会决议公告》
证券之星 · 09-14
股市必读:华润三九新发布《2026年第二次临时股东会决议公告》
华润三九新提交“艾倍易”、“艾普易”等7件商标注册申请
证券之星 · 09-11
华润三九新提交“艾倍易”、“艾普易”等7件商标注册申请
股市必读:华润三九新发布《2026年第二次临时股东会决议公告》
证券之星 · 09-11
股市必读:华润三九新发布《2026年第二次临时股东会决议公告》
华特达因:截至目前,公司未收到任何有关华润三九拟合并或收购本公司的书面或口头信息
证券之星 · 09-09
华特达因:截至目前,公司未收到任何有关华润三九拟合并或收购本公司的书面或口头信息
股市必读:华润三九新发布《董事会2026年第九次会议决议公告》
证券之星 · 09-02
股市必读:华润三九新发布《董事会2026年第九次会议决议公告》
华润三九(000999)披露关于2026年第二次临时股东会增加临时提案暨股东会补充通知的公告,9月1日股价下跌0.37%
证券之星 · 09-01
华润三九(000999)披露关于2026年第二次临时股东会增加临时提案暨股东会补充通知的公告,9月1日股价下跌0.37%
股市必读:华润三九新发布《董事会2026年第八次会议决议公告》
证券之星 · 08-27
股市必读:华润三九新发布《董事会2026年第八次会议决议公告》
华润三九(000999)披露2026年第二次临时股东大会通知,8月25日股价上涨2.16%
证券之星 · 08-25
华润三九(000999)披露2026年第二次临时股东大会通知,8月25日股价上涨2.16%
国金证券:给予华润三九买入评级
证券之星 · 08-24
国金证券:给予华润三九买入评级
图解华润三九中报:第二季度单季净利润同比增长9.12%
证券之星 · 08-22
图解华润三九中报:第二季度单季净利润同比增长9.12%
华润三九(000999)披露2026年半年度报告,8月21日股价下跌3.67%
证券之星 · 08-21
华润三九(000999)披露2026年半年度报告,8月21日股价下跌3.67%
华润三九:公司正在推进“十五五”规划的相关工作
证券之星 · 08-21
华润三九:公司正在推进“十五五”规划的相关工作
加载更多
公司概况
公司名称:
华润三九医药股份有限公司
所属行业:
医药制造业
上市日期:
2000-03-09
主营业务:
华润三九医药股份有限公司的主营业务是高质量医药健康产品创新研发和智能制造。公司的主要产品是999感冒灵、999皮炎平、参附注射液、注射用头孢、免煎中药、三九胃泰颗粒、正天丸、血塞通软胶囊、天麻素注射液、复方丹参滴丸。2026年7月召开国家科学技术奖励大会,华润三九再次荣获国家科学技术进步奖二等奖,目前公司已获得10项国家科技进步二等奖。
发行价格:
8.45
{"stockData":{"symbol":"000999","market":"SZ","secType":"STK","nameCN":"华润三九","latestPrice":24.19,"timestamp":1790751798000,"preClose":23.44,"halted":0,"volume":11093747,"delay":0,"changeRate":0.032,"floatShares":1663000000,"shares":1664000000,"eps":1.9689,"marketStatus":"已收盘","change":0.75,"latestTime":"09-30 15:00:00","open":23.44,"high":24.25,"low":23.42,"amount":266000000,"amplitude":0.0354,"askPrice":24.19,"askSize":363,"bidPrice":24.17,"bidSize":65,"shortable":0,"etf":0,"ttmEps":1.9689,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791423000000},"marketStatusCode":5,"adr":0,"adjPreClose":23.44,"symbolType":"stock","openAndCloseTimeList":[[1790731800000,1790739000000],[1790744400000,1790751600000]],"highLimit":25.78,"lowLimit":21.1,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1664217858,"isCdr":false,"pbRate":1.71,"roa":"--","peRate":12.286048,"roe":"7.31%","epsLYR":2.06,"committee":-0.789517,"marketValue":40257000000,"turnoverRate":0.0067,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-10-08。","floatMarketCap":40217000000},"requestUrl":"/m/hq/s/000999","defaultTab":"news","newsList":[{"id":"2668183006","title":"华润三九半年营销费用41亿,挣来16.7亿净利润","url":"https://stock-news.laohu8.com/highlight/detail?id=2668183006","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668183006?lang=zh_cn&edition=full","pubTime":"2026-09-20 15:57","pubTimestamp":1789891020,"startTime":"0","endTime":"0","summary":"财报数据显示,2026年上半年华润三九实现营收150.14亿元,同比小幅增长1.37%。但盈利端明显承压,当期归母净利润为16.71亿元,同比下滑7.96%。2026年上半年,华润三九销售费用高达41.58亿元,占总营收比重接近三成。数据显示,上半年华润三九CHC板块实现收入61.32亿元,同比大幅下滑23.29%,板块营收缩水超两成。核心现金牛业务大幅下滑,叠加居高不下的销售费用,让华润三九的经营矛盾彻底暴露。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-20/doc-inisnhax2557307.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["000999"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667608273","title":"华特达因:华润三九是公司维生素D滴剂(胶囊型)产品在中国境内的独家代理商","url":"https://stock-news.laohu8.com/highlight/detail?id=2667608273","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667608273?lang=zh_cn&edition=full","pubTime":"2026-09-16 15:07","pubTimestamp":1789542445,"startTime":"0","endTime":"0","summary":"证券之星消息,华特达因(000915)09月16日在投资者关系平台上答复投资者关心的问题。投资者提问:华润三九独家代理华特达因“伊D新”维D滴剂,借助OTC渠道铺货?华特达因回复:您好!华润三九是公司维生素D滴剂(胶囊型)产品在中国境内的独家代理商,公司借助华润三九OTC市场的运作能力和渠道优势,进行该产品的全渠道布局和市场推广。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600018789.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0012","BK0060","BK0122","BK0239","BK0185","BK0183","BK0188","000915","BK0196","BK0186","BK0028","000999","BK0010"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667646812","title":"“求‘你们’中秋别团圆了”,400亿中药龙头广告翻车","url":"https://stock-news.laohu8.com/highlight/detail?id=2667646812","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667646812?lang=zh_cn&edition=full","pubTime":"2026-09-15 18:01","pubTimestamp":1789466460,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会!9月14日,有江苏网友在社交平台晒出三九胃泰的一则广告,文案写着:“求‘你们’中秋别团圆了。”","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2026-09-15/doc-inirxats8584192.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0028","BK0175","BK0188","BK0185","BK0196","BK0010","000999","BK0183","BK0239","BK0060","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667654346","title":"华润三九:公司无相关计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2667654346","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667654346?lang=zh_cn&edition=full","pubTime":"2026-09-14 17:15","pubTimestamp":1789377311,"startTime":"0","endTime":"0","summary":"证券之星消息,华润三九(000999)09月14日在投资者关系平台上答复投资者关心的问题。投资者提问:贵公司是否要收购或合并华特达因?华润三九回复:您好,公司无相关计划。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400022033.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","BK0028","BK0196","BK0239","BK0060","BK0010","BK0185","BK0188","BK0175","BK0012","000999"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667651292","title":"华润三九:公司及子公司高度重视中选产品的落地执行与市场转化","url":"https://stock-news.laohu8.com/highlight/detail?id=2667651292","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667651292?lang=zh_cn&edition=full","pubTime":"2026-09-14 17:06","pubTimestamp":1789376785,"startTime":"0","endTime":"0","summary":"证券之星消息,华润三九(000999)09月14日在投资者关系平台上答复投资者关心的问题。投资者提问:集采中标后,如果医院不勾你的标,销量也一样上不去,目前第12批国采二轮勾标已开启,这将意味着锁定未来3-5年甚至更长时间的市场,随着公司集采中标越来越多,在集采中标产品勾标这一重要环节上,贵公司及下属公司是如何管理的?谢谢!华润三九回复:您好,公司及子公司高度重视中选产品的落地执行与市场转化。公司积极推进医疗机构落地,争取扩大医疗终端覆盖,同时加强全产业链运营能力,做好中选药品的供应保障。感谢您的关注。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400021817.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0196","000999","BK0183","BK0010","BK0060","BK0012","BK0185","BK0175","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667651296","title":"华润三九:中药1.1类创新药枣仁宁心滴丸于2026年6月获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2667651296","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667651296?lang=zh_cn&edition=full","pubTime":"2026-09-14 17:03","pubTimestamp":1789376589,"startTime":"0","endTime":"0","summary":"证券之星消息,华润三九09月14日在投资者关系平台上答复投资者关心的问题。华润三九目前在创新中药或者创新药方面有何新的探索?中药1.1类创新药枣仁宁心滴丸于 2026年6月获批上市。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400021716.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0185","BK0010","BK0239","159992","06978","BK0012","000999","BK0028","BK0188","BK1574","BK0060","BK0183","BK1161","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667065124","title":"华润三九:坚持“创新+品牌”双轮驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2667065124","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667065124?lang=zh_cn&edition=full","pubTime":"2026-09-14 17:00","pubTimestamp":1789376427,"startTime":"0","endTime":"0","summary":"证券之星消息,华润三九09月14日在投资者关系平台上答复投资者关心的问题。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400021648.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","000999","BK0196","BK0188","BK0060","BK0239","BK0010","BK0012","BK0185","BK0183","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667516556","title":"华润三九:坚持以临床价值为导向","url":"https://stock-news.laohu8.com/highlight/detail?id=2667516556","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667516556?lang=zh_cn&edition=full","pubTime":"2026-09-14 16:54","pubTimestamp":1789376054,"startTime":"0","endTime":"0","summary":"证券之星消息,华润三九(000999)09月14日在投资者关系平台上答复投资者关心的问题。投资者提问:临床价值越来越受到重视,也是产品特别是新产品通过医保谈判,得以体现产品价值和相应价格的重要依据,请问公司在这方面是怎么应对开展工作的?是否达到预期?华润三九回复:您好,公司坚持以临床价值为导向,搭建完善高等级循证医学证据体系,持续产出高质量SCI 学术论文,夯实产品学术竞争力。感谢您的关注。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400021535.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0175","BK0188","BK0183","BK0028","BK0060","BK0010","BK0012","BK0185","BK0239","000999"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667802026","title":"股市必读:华润三九新发布《2026年第二次临时股东会决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2667802026","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667802026?lang=zh_cn&edition=full","pubTime":"2026-09-14 02:28","pubTimestamp":1789324091,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘,华润三九报收于23.89元,下跌2.09%,换手率0.6%,成交量9.95万手,成交额2.39亿元。当日关注点交易信息汇总:9月11日主力资金净流出704.07万元,占总成交额2.95%;游资资金净流入1555.84万元,占总成交额6.52%。公司公告汇总:华润三九于9月10日召开2026年第二次临时股东会,审议通过2026年半年度权益分派预案、续聘2026年度审计机构、购买银行理财产品及补选公司董事四项议案,出席会议股东代表股份占公司有表决权股份总数的65.3037%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400000978.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0183","BK0028","BK0185","BK0010","000999","BK0239","BK0196","BK0060","BK0012","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666007519","title":"华润三九新提交“艾倍易”、“艾普易”等7件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2666007519","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666007519?lang=zh_cn&edition=full","pubTime":"2026-09-11 07:14","pubTimestamp":1789082065,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示,近日华润三九医药股份有限公司新提交“艾倍易”、“艾普易”等7件商标注册申请。商标申请详情如下:今年以来华润三九医药股份有限公司新申请注册商标34件,截止目前公司共持有注册商标4050件,另有433件商标尚在注册申请中。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100013342.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","BK0239","BK0188","000999","BK0060","BK0012","BK0196","BK0185","BK0175","BK0028","BK0010"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666186835","title":"股市必读:华润三九新发布《2026年第二次临时股东会决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2666186835","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666186835?lang=zh_cn&edition=full","pubTime":"2026-09-11 02:55","pubTimestamp":1789066512,"startTime":"0","endTime":"0","summary":"公司公告汇总:华润三九于9月10日召开2026年第二次临时股东会,审议通过半年度权益分派预案、续聘审计机构、购买银行理财产品及补选董事四项议案,出席会议股东代表股份占公司有表决权股份总数的65.3037%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100002967.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0010","BK0028","BK0185","BK0012","BK0188","BK0239","BK0175","000999","BK0183","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666301729","title":"华特达因:截至目前,公司未收到任何有关华润三九拟合并或收购本公司的书面或口头信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2666301729","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666301729?lang=zh_cn&edition=full","pubTime":"2026-09-09 11:38","pubTimestamp":1788925103,"startTime":"0","endTime":"0","summary":"证券之星消息,华特达因(000915)09月09日在投资者关系平台上答复投资者关心的问题。投资者提问:华润三九是否要合并或收购贵公司华特达因啊?华特达因回复:您好!截至目前,公司未收到任何有关华润三九拟合并或收购本公司的书面或口头信息。公司所有重大事项,均以巨潮资讯网(www.cninfo.com.cn)以及《中国证券报》《证券时报》《证券日报》等法定信息披露媒体发布的公告为准。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900015248.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000915","BK0196","BK0010","BK0060","BK0028","BK0185","000999","BK0183","BK0188","BK0239","BK0186","BK0122","BK0012","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664769863","title":"股市必读:华润三九新发布《董事会2026年第九次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664769863","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664769863?lang=zh_cn&edition=full","pubTime":"2026-09-02 01:59","pubTimestamp":1788285553,"startTime":"0","endTime":"0","summary":"公司公告汇总董事会2026年第九次会议决议公告华润三九董事会2026年第九次会议于2026年9月1日以通讯方式召开,应到董事11人,实到10人,由董事长邱华伟主持。关于2026年第二次临时股东会增加临时提案暨股东会补充通知的公告华润三九于2026年8月26日发布2026年第二次临时股东会通知,定于2026年9月10日召开,审议2026年半年度权益分派预案、续聘2026年年度审计机构、购买银行理财产品等议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200002137.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0060","BK0183","BK0196","BK0239","BK0175","000999","BK0028","BK0185","BK0188","BK0010"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664857998","title":"华润三九(000999)披露关于2026年第二次临时股东会增加临时提案暨股东会补充通知的公告,9月1日股价下跌0.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664857998","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664857998?lang=zh_cn&edition=full","pubTime":"2026-09-01 22:41","pubTimestamp":1788273674,"startTime":"0","endTime":"0","summary":"截至2026年9月1日收盘,华润三九报收于24.41元,较前一交易日下跌0.37%,最新总市值为406.24亿元。近日,华润三九医药股份有限公司发布《关于2026年第二次临时股东会增加临时提案暨股东会补充通知的公告》。公告显示,公司董事会于2026年8月26日发布召开2026年第二次临时股东会的通知,定于2026年9月10日召开会议,审议2026年半年度权益分派预案、续聘2026年年度审计机构、购买银行理财产品等议案。董事会审议通过该临时提案,并提交股东会选举。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100043239.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","BK0239","BK0012","BK0188","BK0060","BK0183","BK0028","BK0185","BK0196","000999","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662746547","title":"股市必读:华润三九新发布《董事会2026年第八次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662746547","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662746547?lang=zh_cn&edition=full","pubTime":"2026-08-27 01:15","pubTimestamp":1787764513,"startTime":"0","endTime":"0","summary":"截至2026年8月26日收盘,华润三九报收于24.45元,上涨1.41%,换手率0.67%,成交量11.12万手,成交额2.72亿元。当日关注点交易信息汇总:8月26日主力资金净流出3330.15万元,占总成交额12.26%。公司公告汇总:董事会审议通过召开2026年第二次临时股东会的议案,会议定于9月10日举行,审议半年度权益分派预案、续聘审计机构及购买银行理财产品等事项。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700003704.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0010","BK0183","BK0060","BK0185","BK0188","BK0196","BK0175","BK0012","000999"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662758744","title":"华润三九(000999)披露2026年第二次临时股东大会通知,8月25日股价上涨2.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662758744","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662758744?lang=zh_cn&edition=full","pubTime":"2026-08-25 22:21","pubTimestamp":1787667701,"startTime":"0","endTime":"0","summary":"截至2026年8月25日收盘,华润三九报收于24.11元,较前一交易日上涨2.16%,最新总市值为401.24亿元。近日,华润三九医药股份有限公司发布《关于召开2026年第二次临时股东会的通知》。公告显示,公司将于2026年9月10日召开2026年第二次临时股东会,会议由董事会召集,现场会议时间为当日14:30,网络投票时间为9月10日9:15至15:00。股东可通过现场或网络投票方式参与表决,中小股东将单独计票并披露结果。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500050700.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","000999","BK0175","BK0012","BK0239","BK0028","BK0010","BK0060","BK0188","BK0185","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661424116","title":"国金证券:给予华润三九买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2661424116","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661424116?lang=zh_cn&edition=full","pubTime":"2026-08-24 08:25","pubTimestamp":1787531120,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司甘坛焕,王奔奔近期对华润三九进行研究并发布了研究报告《内生稳健,期待并购成效释放》,给予华润三九买入评级。最新盈利预测明细如下:该股最近90天内共有4家机构给出评级,买入评级4家;过去90天内机构目标均价为37.5。本文数据来源于国金证券股份有限公司,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400002618.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000999"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661429404","title":"图解华润三九中报:第二季度单季净利润同比增长9.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661429404","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661429404?lang=zh_cn&edition=full","pubTime":"2026-08-22 01:57","pubTimestamp":1787335067,"startTime":"0","endTime":"0","summary":"证券之星消息,华润三九2026年中报显示,上半年度公司主营收入150.14亿元,同比上升1.37%;归母净利润16.71亿元,同比下降7.96%;扣非净利润15.97亿元,同比下降5.93%;其中2026年第二季度,公司单季度主营收入68.84亿元,同比下降13.48%;单季度归母净利润5.95亿元,同比上升9.12%;单季度扣非净利润5.49亿元,同比上升14.47%;负债率29.92%,投资收益362.0万元,财务费用2704.95万元,毛利率56.79%。财报数据概要请见下图:本文数据来源于华润三九2026年中报,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082200002076.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000999"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661296851","title":"华润三九(000999)披露2026年半年度报告,8月21日股价下跌3.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661296851","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661296851?lang=zh_cn&edition=full","pubTime":"2026-08-21 22:07","pubTimestamp":1787321244,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘,华润三九报收于24.14元,较前一交易日下跌3.67%,最新总市值为401.74亿元。该股当日开盘24.72元,最高24.98元,最低24.08元,成交额达3.93亿元,换手率为0.97%。近日,华润三九披露2026年半年度报告。报告显示,报告期内营业收入为15,013,612,888.84元,同比增长1.37%;归属于上市公司股东的净利润为1,670,783,226.54元,同比下降7.96%;扣除非经常性损益后的净利润为1,596,956,915.76元,同比下降5.93%;经营活动产生的现金流量净额为2,422,761,385.16元,同比下降15.29%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100045093.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","BK0239","BK0188","000999","BK0060","BK0012","BK0196","BK0185","BK0175","BK0028","BK0010"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661298719","title":"华润三九:公司正在推进“十五五”规划的相关工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2661298719","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661298719?lang=zh_cn&edition=full","pubTime":"2026-08-21 20:51","pubTimestamp":1787316693,"startTime":"0","endTime":"0","summary":"证券之星消息,华润三九(000999)08月20日在投资者关系平台上答复投资者关心的问题。投资者提问:公司在稳住OTC基本盘的同时,正在加快创新产品临床与商业化进度,形成新的增长曲线,请问公司的十五五规划什么时候出台?对新的增长曲线,会有哪些举措?谢谢华润三九回复:您好,公司正在推进“十五五”规划的相关工作,公司围绕发展战略,持续聚焦主业,努力推动高质量发展,感谢您的关注。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100042953.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0175","BK0196","BK0183","BK0060","BK0012","BK0185","BK0239","BK0028","BK0010","000999"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1790865334969,"stockEarnings":[{"period":"1week","weight":0.0181},{"period":"1month","weight":-0.0127},{"period":"3month","weight":0.0121},{"period":"6month","weight":-0.1189},{"period":"1year","weight":-0.1034},{"period":"ytd","weight":-0.1288}],"compareEarnings":[{"period":"1week","weight":-0.024},{"period":"1month","weight":-0.0362},{"period":"3month","weight":-0.0463},{"period":"6month","weight":-0.0098},{"period":"1year","weight":-0.0105},{"period":"ytd","weight":-0.0319}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华润三九医药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"96364人(较上一季度减少0.53%)","perCapita":"17252股","listingDate":"2000-03-09","address":"广东省深圳市龙华区观湖街道观澜高新园区观清路1号","registeredCapital":"166421万元","survey":" 华润三九医药股份有限公司的主营业务是高质量医药健康产品创新研发和智能制造。公司的主要产品是999感冒灵、999皮炎平、参附注射液、注射用头孢、免煎中药、三九胃泰颗粒、正天丸、血塞通软胶囊、天麻素注射液、复方丹参滴丸。2026年7月召开国家科学技术奖励大会,华润三九再次荣获国家科学技术进步奖二等奖,目前公司已获得10项国家科技进步二等奖。","listedPrice":8.45},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华润三九(000999)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华润三九(000999)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华润三九,000999,华润三九股票,华润三九股票老虎,华润三九股票老虎国际,华润三九行情,华润三九股票行情,华润三九股价,华润三九股市,华润三九股票价格,华润三九股票交易,华润三九股票购买,华润三九股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华润三九(000999)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华润三九(000999)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}